'Uncategorized' Category
By Simmons Hanly Conroy | October 29, 2013
Hawaii Dept. of Health Links Diet Supplement OxyElite Pro to Liver Failure
USPLabs, the manufacturer of the diet supplement called OxyELITE Pro, has halted distribution of the drug nationwide following multiple cases of liver failure linked to the supplement discovered by the Hawaii Department… Read More
By Simmons Hanly Conroy | October 25, 2013
FDA Issues Black Box Warning on Two Cancer Drugs
The hepatitis B warnings on two blood cancer drugs were recently strengthened by the Food and Drug Administration (FDA), according to Fox News. The strengthened warnings were issued to reflect the risk of… Read More
By Simmons Hanly Conroy | September 6, 2013
FDA Strengthens Warning on Lariam, Anti-Malaria Drug
Recently, the Food and Drug Administration (FDA) announced that the commonly used anti-malaria drug, called mefloquine hydrochloride (brand name Lariam) must have a “black box” warning on its label. The drug has… Read More
By Simmons Hanly Conroy | August 29, 2013
Study Links Calcium-Channel Blockers to Breast Cancer
Calcium-channel blockers (CCBs) may be associated with a higher risk of breast cancer, according to a new study. Published in the journal JAMA Internal Medicine, the study looked at the effects of the… Read More
By Simmons Hanly Conroy | August 26, 2013
C.R. Bard Reaches Settlement in Second Lawsuit Trial Over its Transvaginal Mesh Product
C.R. Bard, a medical technologies developer, manufacturer and marketer commonly referred to simply as Bard, has reached a settlement in the second lawsuit trial of the multidistrict litigation for its transvaginal mesh… Read More
By Simmons Hanly Conroy | July 31, 2013
Roche Halts Development of New Diabetes Drug Due to Safety Concerns
Swiss pharmaceutical giant Roche has stopped further development of its new diabetes drug called aleglitazar. This decision could increase safety concerns for drugs similar to aleglitazar, including the controversial medication called Avandia.… Read More
By Simmons Hanly Conroy | July 29, 2013
Advertising Nets Lipitor Better Sales Despite Dangerous Side Effects, Generic Competition
Pharmaceutical company Pfizer’s lucrative cholesterol drug Lipitor is expected to generate approximately $3 billion in revenue by 2015, according to a recent report by AARP’s Public Policy Institute. The cholesterol medication is… Read More
By Simmons Hanly Conroy | July 8, 2013
FDA To Revisit Rule Blocking Lawsuits Against Generic Drug Makers
The U.S. Food & Drug Administration has indicated it might allow generic drug manufacturers to revise their products’ safety labels independent of their name brand counterparts. If this change is made, consumers harmed by… Read More
By Simmons Hanly Conroy | April 29, 2013
Study Finds Januvia May Damage Pancreas
Januvia is a once-daily medication prescribed to help lower blood sugar levels in patients with type 2 diabetes. Also known by the name Sitagliptin, the medication can be used in combination with… Read More
By Simmons Hanly Conroy | April 11, 2013
New Type of Diabetes Drug Approved by FDA
A Johnson & Johnson drug that treats type 2 diabetes in a new way is now approved by the U.S. Food and Drug Administration (FDA). Invokana, as the drug is known, will… Read More
